A recent report estimated that approximately 1 million adults were living with multiple sclerosis in the United States . Although multiple sclerosis is rarely the direct cause of death, its debilitating effects on normal body functions can result in considerable disruption to daily living and life roles including work, physical independence, mobility, social interaction, and participation in leisure activities . This study estimated the total economic burden of multiple sclerosis in the United States in 2019 .

This study used a prevalence-based approach to estimate the national economic burden of multiple sclerosis . Claims from 3 sources were used to obtain direct costs and a survey was developed to collect indirect costs from 946 patients with multiple sclerosis . Direct medical costs reflected the difference in the total average annual amount paid for Patients with multiple sclerosis vs matched controls without multiple sclerosis . Future earnings loss due to premature death attributable to multiple sclerosis was calculated using Centers for Disease Control and Prevention mortality data and Medicare claims data .


multiple sclerosis is a costly chronic disease, with direct costs of prescription drugs and indirect productivity loss being important cost drivers . Our findings suggested that the burden of multiple sclerosis in the United States has been underestimated .
